Intravenous sildenafil (Viagra®) and pulmonary vascular resistance in children with congenital heart disease

被引:0
|
作者
Schulze-Neick, I [1 ]
Li, J [1 ]
Petros, A [1 ]
Redington, AN [1 ]
机构
[1] Great Ormond St Hosp Children, Cardiothorac Unit, London WC1, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:76 / 76
页数:1
相关论文
共 50 条
  • [1] Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease
    Fraisse, Alain
    Butrous, Ghazwan
    Taylor, Mary B.
    Oakes, Michael
    Dilleen, Maria
    Wessel, David L.
    INTENSIVE CARE MEDICINE, 2011, 37 (03) : 502 - 509
  • [2] Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease
    Alain Fraisse
    Ghazwan Butrous
    Mary B. Taylor
    Michael Oakes
    Maria Dilleen
    David L. Wessel
    Intensive Care Medicine, 2011, 37 : 502 - 509
  • [3] Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease
    Schulze-Neick, I
    Hartenstein, P
    Li, J
    Stiller, B
    Nagdyman, N
    Hübler, M
    Butrous, G
    Petros, A
    Lange, P
    Redington, AN
    CIRCULATION, 2003, 108 (10) : 167 - 173
  • [4] PULMONARY VASCULAR-RESISTANCE IN CHILDREN WITH CONGENITAL HEART-DISEASE
    DAVIES, NJH
    SHINEBOURNE, EA
    SCALLAN, MJ
    SOPWITH, TA
    DENISON, DM
    THORAX, 1984, 39 (12) : 895 - 900
  • [5] Sildenafil lowers pulmonary vascular resistance in children after heart surgery
    Schulze-Neick, I
    Dietz, P
    Stiller, B
    Nagdyman, N
    Butrous, G
    Falke, K
    Redington, AN
    Lange, PE
    EUROPEAN HEART JOURNAL, 2002, 23 : 490 - 490
  • [6] Pulmonary vascular resistance and compliance in pulmonary blood flow alterations in children with congenital heart disease
    Iwaya, Yuka
    Muneuchi, Jun
    Sugitani, Yuichiro
    Watanabe, Mamie
    HEART AND VESSELS, 2022, 37 (07) : 1283 - 1289
  • [7] Pulmonary vascular resistance and compliance in pulmonary blood flow alterations in children with congenital heart disease
    Yuka Iwaya
    Jun Muneuchi
    Yuichiro Sugitani
    Mamie Watanabe
    Heart and Vessels, 2022, 37 : 1283 - 1289
  • [8] CALCULATING PULMONARY VASCULAR-RESISTANCE IN CHILDREN WITH CONGENITAL HEART-DISEASE - REPLY
    WALDMAN, JD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1984, 4 (05) : 1071 - 1071
  • [9] Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension
    Shekerdemian, LS
    Ravn, HB
    Penny, DJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (08) : 1098 - 1102
  • [10] Evaluation of pulmonary vascular resistance and vasoreactivity testing with oxygen in children with congenital heart disease and pulmonary arterial hypertension
    Cevik, Ayhan
    Kula, Serdar
    Olgunturk, Rana
    Tunaoglu, Sedef
    Oguz, Deniz
    Saylan, Berna
    Sanli, Cihat
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2014, 14 (02): : 196 - 198